ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

IG Report Clears Shubik Of Conflict Of Interest Change

October 6, 1978

Women’s Health Was ‘Highest Priority’ Of House Committee

July 31, 1992

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994

Endoscopic Surgery Provides Equal Or Better Results

September 30, 2005

Studies Started On Use Of Heroin, THC for Pain, Discomfort Therapy

October 13, 1978

Q & A With Shannon Brownlee: Task Force Independence at Stake In Debate over PSA Screening

October 6, 2011